文献速递口腔颌面外科

颞下颌关节紊乱病与口腔健康相关生活质量:系统综述与荟萃分析

Non-Syndromic Hereditary Gingival Fibromatosis Driven by Chymase Deficiency Is Attenuated by Verteporfin-Loaded Exosomes.
PubMed 文献 · J Clin Periodontol · 2025-12-12

该系统综述与荟萃分析评估了颞下颌关节紊乱病(TMD)对口腔健康相关生活质量(OHRQoL)的影响。

要点

  • TMD患者OHRQoL显著差于无TMD者,效应量为大效应。
  • 疼痛强度越高,OHRQoL受损越严重。
  • 临床应关注TMD患者的生活质量并早期干预。

主要发现

  • 亚组分析显示疼痛强度与OHRQoL受损程度呈正相关。

临床怎么用

  • 临床评估TMD患者时应同时关注OHRQoL,将其作为治疗目标之一。
  • 对疼痛强度高的TMD患者应优先干预以改善生活质量。

局限性

  • 纳入研究多为横断面设计,无法确定因果关系。
  • 多数研究来自高收入国家,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To identify novel non-syndromic hereditary gingival fibromatosis (nsHGF)-associated pathogenic variants and discover therapeutic targets for innovative, minimally invasive therapies. MATERIALS AND METHODS: Whole-genome sequencing was performed to identify the pathogenic variant in a family with nsHGF. Levels of fibrosis markers and the yes-associated protein/transcriptional coactivator with PDZ-binding motif (YAP/TAZ) in gingival fibroblasts were measured by qPCR, western blot and immunofluorescence. Conditioned medium from gingival fibroblasts was used to treat THP-1-derived macrophages. In vivo pro-fibrotic behaviour of CHYMASE-silenced gingival fibroblasts and verteporfin-loaded exosome efficacy were evaluated in NOD/SCID mice. RESULTS: We identified a novel CHYMASE (CMA1) nonsense mutation (c.114C>A, p.Tyr38*) in the nsHGF family. This mutation caused chymase deficiency in the patient's gingival fibroblasts, directly leading to extracellular matrix (ECM) overproduction through YAP/TAZ activation. Moreover, CHYMASE-silenced gingival fibroblasts promoted interleukin-6 (IL-6) secretion by macrophages, thereby amplifying pro-fibrotic responses in gingival fibroblasts. The YAP inhibitor verteporfin suppressed ECM overproduction in CHYMASE-silenced gingival fibroblasts. In vivo, topical administration of verteporfin-loaded exosomes significantly attenuated chymase deficiency-induced fibrosis. CONCLUSION: Our findings support the pathogenic role of the CHYMASE mutation in nsHGF, establish chymase deficiency and consequent YAP/TAZ activation as the underlying mechanism and propose verteporfin-loaded exosomes as a promising therapeutic strategy for nsHGF-associated gingival overgrowth.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Chen X, Guo Y, Qing Y, et al. Non-Syndromic Hereditary Gingival Fibromatosis Driven by Chymase Deficiency Is Attenuated by Verteporfin-Loaded Exosomes. J Clin Periodontol. 2025. PMID: 41386781. doi:10.1111/jcpe.70077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。